Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$85,333
+$36,934 QoQ
Shares Held
336
+69.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4,586
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $2,738,678 across 11 Drug Manufacturers - General names. JNJ ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
833 | $999,123 | |
| 2 | NVO |
Novo Nordisk A S
|
8,881 | $425,755 | |
| 3 | ABBV |
AbbVie Inc.
|
1,197 | $301,212 | |
| 4 | PFE |
Pfizer Inc
|
9,522 | $229,288 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,760 | $226,160 | |
| 6 | AMGN |
Amgen Inc
|
597 | $216,185 | |
| 7 | AZN |
Astrazeneca PLC
|
1,049 | $198,911 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
336 | $85,333 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,333 | 336 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $48,399 | 198 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $42,217 | 204 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $35,600 | 192 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $21,537 | 141 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $1,001,673 | 6,040 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $902,283 | 6,239 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $22,850 | 141 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $26,308 | 180 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $27,999 | 177 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $91,279,731 | 582,364 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $84,231,312 | 540,811 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $151,521,144 | 915,425 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $136,449,445 | 880,319 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $132,148,507 | 748,081 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $92,151,702 | 564,102 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $80,234,697 | 452,001 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $38,230,637 | 215,712 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,257,609 | 159,336 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $33,603,951 | 208,074 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $26,464,163 | 160,642 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $17,543,047 | 106,742 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,984,531 | 38,026 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,041,618 | 20,430 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,087,772 | 7,735 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,195,904 | 9,120 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||